Natasha Dzimitrowicz

Natasha Dzimitrowicz is an Associate Director of Portfolio Strategy at Jazz Pharmaceuticals since April 2020, where responsibilities include conducting strategic and commercial assessments for product development and clinical trial designs in sleep, psychiatry, and oncology, with a focus on optimizing ex-US value and access in Europe, the UK, and Japan. Prior to this, Natasha was an Associate Consultant at ZS from July 2017 to April 2020, managing market access and pricing research projects, and developing insights into the global oncology, neurology, and respiratory healthcare markets. Natasha also briefly worked with BioTechnology Yes in November 2015 in a workshop on Plants, Microbes, and Environment. Academic qualifications include a PhD in Cell/Cellular and Molecular Biology and a B.Sc. in Biochemistry, both from the University of Warwick, along with A levels and GCSEs from Hitchin Girls' School.